Table 7 Multivariate analyses of clinical and tumor factors associated with Epcam in 39 HCC patients
Variable | P value | OR | 95%CI |
|---|---|---|---|
Differentiation (well/moderate/poor) | 0.056 | 5.01 | 0.96-26.21 |
TACE Treatment/not | 0.025 | 5.88 | 1.25-27.80 |
Variable | P value | OR | 95%CI |
|---|---|---|---|
Differentiation (well/moderate/poor) | 0.056 | 5.01 | 0.96-26.21 |
TACE Treatment/not | 0.025 | 5.88 | 1.25-27.80 |